background
chronic
cough
children
diagnost
challeng
object
discov
util
nasal
dipstick
polymeras
chain
reaction
pcr
dna
analysi
differenti
bacteri
sinus
caus
chronic
cough
identifi
pathogen
nasal
caviti
method
recruit
patient
year
age
cough
last
longer
week
group
control
allerg
rhiniti
group
control
without
respiratori
symptom
group
base
symptom
result
nasal
secret
assay
nasal
endoscopi
diagnosi
clinic
bacteri
sinus
made
identifi
potenti
pathogen
quantit
pcr
nasal
secret
result
group
cough
clinic
bacteri
sinus
n
eight
patient
bacteri
sinus
associ
domin
potenti
pathogen
bacteria
ppb
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
group
cough
without
clinic
bacteri
sinus
n
none
domin
ppb
group
allerg
rhiniti
n
none
domin
ppb
group
asymptomat
n
none
domin
ppb
twenti
group
colon
staphylococcu
aureu
fifti
colon
staphylococcu
epidermidi
corynebacterium
pseudodiphtheriticum
dolosigranulum
pigrum
conclus
children
chronic
cough
clinician
util
simpl
inexpens
nasal
secret
dipstick
assay
rapid
diagnosi
sinus
identifi
ppb
dnapcr
test
specif
antibiot
treatment
chronic
cough
defin
daili
cough
last
week
longer
children
year
age
caus
chronic
cough
includ
congenit
defect
asthma
foreign
bodi
aspir
infect
allerg
diseas
gastroesophag
reflux
tumor
rare
caus
among
common
etiolog
includ
asthma
upper
airway
cough
syndrom
protract
bacteri
bronchiti
nonspecif
cough
diagnosi
asthma
cough
variant
asthma
made
basi
naepp
criteria
respons
bronchodil
upper
airway
cough
syndrom
common
entiti
like
trigger
postnas
drip
due
either
allerg
nonallerg
rhiniti
bacteri
nonbacteri
sinus
protract
bacteri
bronchiti
recogn
one
common
caus
chronic
wet
cough
especi
young
children
year
age
asthma
condit
list
rule
upper
airway
cough
syndrom
protract
bacteri
bronchiti
need
consid
like
diagnos
approach
clinic
entiti
goal
promptli
detect
patient
bacteri
sinus
involv
pathogen
treat
appropri
antibiot
end
decid
employ
novel
method
describ
huang
small
report
nasal
secret
dipstick
assay
highli
correl
sinu
imag
studi
could
util
diagnosi
sinus
employ
simpl
approach
obviou
reason
speed
costeffect
avoid
radiat
risk
associ
sinu
imag
studi
also
sought
equal
simpl
rapid
method
identif
pathogen
suspect
sinus
posit
find
imag
studi
sinus
opac
thicken
line
indic
presenc
inflamm
possibl
infect
may
poor
correl
clinic
diseas
reveal
inform
etiolog
although
sinu
punctur
would
yield
inform
perform
nonsurg
offic
set
studi
document
nasal
cultur
poor
reflect
microb
sinu
caviti
therefor
analyz
microb
osteomeat
area
util
quantit
pcr
method
attempt
detect
pathogen
may
cohabit
sinu
nasal
caviti
prospect
studi
conduct
approv
institut
review
board
human
subject
committe
la
biomedharborucla
medic
center
inform
consent
obtain
patient
recruit
children
year
age
compos
group
patient
chronic
cough
group
studi
children
cough
longer
week
among
patient
met
clinic
diagnost
criteria
bacteri
sinus
list
subclassifi
group
cough
clinic
bacteri
sinus
group
cough
without
clinic
bacteri
sinus
patient
allerg
rhiniti
group
studi
patient
rhiniti
posit
skin
test
respiratori
allergen
without
cough
lower
respiratori
symptom
subject
without
respiratori
symptom
group
studi
children
without
current
past
respiratori
complaint
seen
routin
physic
checkup
patient
interview
pertin
histori
nasal
secret
assay
quantit
pcr
analysi
nasal
secret
patient
chronic
cough
group
allerg
rhiniti
group
addit
procedur
nasal
endoscopi
allergi
skin
test
clinic
diagnosi
bacteri
sinus
made
patient
met
criteria
consist
posit
clinic
histori
sinus
nasal
endoscopi
nasal
secret
score
explain
clinic
histori
complaint
facial
pain
sinu
pressur
purul
nasal
drainag
consid
posit
histori
nasal
endoscopi
jedm
flexibl
fiberopt
nasopharyngoscop
st
loui
mo
use
applic
oxymetazolin
nasal
spray
lidocain
spray
nostril
time
presenc
purul
discharg
middl
meatu
nasopharynx
consid
strong
indic
bacteri
sinus
nasal
secret
assay
nasal
discharg
obtain
swab
wet
cotton
applic
cm
nasal
antrum
later
aim
middl
meatu
applic
tip
smear
urin
dip
strip
strip
score
compon
protein
nitrit
ph
leukocyt
score
done
accord
protocol
publish
huang
et
al
follow
total
score
sum
individu
score
protein
ph
leukocyt
esteras
nitrit
score
consid
indic
bacteri
sinus
nasal
secret
sampl
collect
insert
swab
nostril
rub
rotat
swab
depth
cm
sent
microgen
diagnost
lubbock
tx
dna
analysi
nasal
microb
rapid
identif
ppb
potenti
pathogen
bacteria
ppv
potenti
pathogen
viru
report
gener
within
hour
sampl
collect
util
rapid
quantit
pcr
method
use
roch
lightcycl
ii
instrument
detect
type
bacteria
bacteri
load
fungu
resist
gene
follow
antibiot
includ
vancomycin
methicillin
betalactam
carbapenem
macrolid
aminoglycosid
tetracyclin
quinolon
presenc
bacteria
identifi
rel
quantiti
abund
report
percentag
total
bacteri
load
subsequ
use
ng
nextgener
sequenc
machin
method
util
univers
intern
transcrib
space
amplicon
sequenc
ion
torrant
person
genom
machin
bacterium
abund
greater
consid
domin
speci
streptococcu
pneumonia
sp
hi
moraxella
catarrhali
mc
classifi
ppb
staphylococcu
epidermidi
se
corynebacterium
pseudodiphtheriticum
cp
dolosigranulum
pigrum
dp
classifi
pnpb
sa
classifi
separ
rhinoviru
parainfluenza
viru
classifi
potenti
pathogen
virus
ppv
classif
elabor
discuss
section
allergi
skin
test
employ
identifi
patient
allerg
rhiniti
group
test
perform
accord
standard
procedur
use
inhal
allergen
stallergen
greer
london
uk
appli
skin
multitest
applic
lincoln
diagnost
decatur
il
allergen
includ
dust
mite
cat
dog
mold
pollen
grass
tree
weed
specif
southern
california
mean
median
standard
deviat
interquartil
rang
comput
continu
variabl
frequenc
percentag
compar
categor
variabl
analysi
varianc
use
outcom
follow
normal
distribut
kruskalw
test
use
nonnorm
continu
outcom
chisquar
fisher
exact
test
use
compar
differ
proport
among
group
sa
softwar
cari
nc
use
data
analys
state
method
section
subject
met
sinus
criteria
classifi
group
nasal
endoscop
find
p
nasal
secret
score
p
highli
sensit
could
use
select
criteria
shown
tabl
tabl
figur
group
clinic
diagnosi
bacteri
sinus
group
carri
ppb
nasal
caviti
higher
percentag
nppb
sa
ppv
present
variou
degre
group
statist
signific
pattern
discern
group
twelv
patient
classifi
nonbacteri
cough
group
sinc
meet
bacteri
sinus
criteria
two
patient
demonstr
presenc
ppb
none
domin
three
patient
demonstr
presenc
ppv
antigen
concomit
ppb
ppv
group
among
patient
allerg
rhiniti
patient
nondomin
ppb
one
patient
carri
ppv
patient
group
report
improv
cough
week
antibiot
treatment
nasal
secret
assay
score
also
decreas
patient
group
symptomat
manag
vari
success
without
use
antibiot
patient
group
test
sensit
aeroallergen
allerg
sensit
present
patient
group
patient
group
children
acut
sinus
usual
defin
symptom
last
less
day
chronic
sinus
longer
day
subacut
sinus
rang
acut
sinus
associ
sinu
pressur
purul
nasal
drainag
cough
presenc
ppb
chronic
subacut
sinus
protract
cough
may
play
promin
role
nasal
symptom
patholog
subacut
sinus
may
resembl
acut
sinus
chronic
sinus
may
involv
inflammatori
process
associ
variou
microb
includ
sa
especi
patient
nasal
polyposi
among
group
patient
patient
chronic
patient
subacut
symptom
data
shown
made
clinic
diagnosi
bacteri
sinus
base
previous
mention
criteria
group
sought
identifi
predomin
bacteria
associ
condit
although
asymptomat
children
may
colon
ppb
middl
meatu
presenc
ppb
nasal
caviti
patient
diagnos
clinic
sinus
may
reveal
pathogen
lee
et
al
report
studi
adult
acut
sinus
nasopharyng
middl
meatal
sampl
grew
ppb
concord
rate
site
want
increas
sensit
microbi
identif
employ
dnabas
molecular
diagnost
recent
studi
indic
molecular
diagnost
approach
yield
much
accur
result
regard
divers
quantiti
microb
present
sinu
nasal
caviti
pcr
result
report
classifi
bacteria
differ
categori
depend
pathogen
potenti
sp
hi
mc
classifi
ppb
sinc
establish
predomin
pathogen
acut
subacut
sinus
previou
studi
se
report
commens
bacterium
nasal
caviti
although
cp
character
pathogen
studi
report
part
natur
microbiota
nare
throat
dp
report
caus
sinus
sa
classifi
separ
presenc
nasal
sinu
caviti
asymptomat
subject
patient
sinus
rhinoviru
parainfluenza
viru
virus
identifi
classifi
potenti
pathogen
virus
ppv
sinc
well
known
caus
upper
respiratori
symptom
seen
tabl
presenc
ppb
domin
speci
nasal
caviti
correl
clinic
diagnosi
bacteri
sinus
p
indic
domin
microb
other
import
element
pathogenesi
presenc
ppb
group
surpris
known
inhabit
nasal
caviti
asymptomat
subject
nondomin
ppb
along
clinic
featur
enabl
clinician
separ
group
one
bacteri
sinus
group
may
repres
combin
recurr
acut
subacut
chronic
sinus
bacteri
infect
ppb
also
report
common
pathogen
associ
acut
otiti
media
protract
bacteri
bronchiti
possibl
patient
may
inde
simultan
sinus
protract
bacteri
bronchiti
sinc
antibiot
treatment
stop
cough
entiti
coexist
via
one
airway
need
explor
futur
group
chronic
cough
like
due
postnas
drip
result
nonbacteri
patholog
allergi
patient
allergen
sensit
shown
tabl
viral
infect
chronic
irrit
although
sa
present
domin
speci
patient
group
pathogen
role
doubt
due
presenc
control
group
staphylococci
present
sinu
aspir
acut
chronic
sinus
nasal
caviti
cr
nasal
polyp
may
play
role
pathogenesi
sinus
especi
adult
also
shown
present
nasal
caviti
asymptomat
subject
compet
relationship
pnpb
presenc
may
transient
colon
rather
infect
presenc
pnpb
group
tabl
figur
consist
recent
studi
reveal
asymptomat
cohort
also
carri
divers
commens
bacteria
nasal
caviti
includ
sa
se
dp
cp
maintain
compet
relationship
among
intrigu
find
presenc
rhinoviru
group
includ
asymptomat
control
indic
colon
necessarili
associ
clinic
symptom
group
patient
carri
ppv
carri
ppb
ppv
indic
virus
bacteria
coexist
rhinoviru
common
viral
pathogen
studi
shown
increas
adhes
ppb
nasal
epitheli
cell
least
compar
uninfect
control
conclus
demonstr
other
children
chronic
cough
sinus
microbi
balanc
sinu
caviti
disturb
ppb
take
domin
detect
simpl
method
dipstick
assay
quantit
dnapcr
test
nasal
secret
therefor
recommend
clinician
util
method
altern
imag
studi
make
diagnosi
bacteri
sinus
offer
specif
therapi
pathogen
rapid
accur
manner
studi
indic
replic
find
refin
potenti
diagnost
capabl
dnabas
method
bacteri
sinus
bronchiti
editor
grate
acknowledg
assist
margaret
keller
md
lynn
smith
md
joaquin
madrena
md
phd
review
manuscript
author
declar
potenti
conflict
interest
respect
research
authorship
andor
public
articl
studi
approv
lo
angel
biom
clinic
trial
registr
http
imedrislabiomedorgdatabas
author
disclos
receipt
follow
financi
support
research
authorship
andor
public
articl
dnabas
analysi
provid
author
free
charg
microgen
diagnost
lubbock
tx
approv
institut
review
board
inform
consent
obtain
subject
particip
project
articl
contain
studi
anim
subject
